J-F. Timsit

853 total citations
20 papers, 126 citations indexed

About

J-F. Timsit is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, J-F. Timsit has authored 20 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Applied Microbiology and Biotechnology and 4 papers in Critical Care and Intensive Care Medicine. Recurrent topics in J-F. Timsit's work include Antibiotic Use and Resistance (6 papers), Nosocomial Infections in ICU (4 papers) and Antibiotic Resistance in Bacteria (3 papers). J-F. Timsit is often cited by papers focused on Antibiotic Use and Resistance (6 papers), Nosocomial Infections in ICU (4 papers) and Antibiotic Resistance in Bacteria (3 papers). J-F. Timsit collaborates with scholars based in France, United Kingdom and United States. J-F. Timsit's co-authors include Martin Llewelyn, A. Sarah Walker, Benedikt Huttner, Jasmin Islam, Paul Little, Alessia Savoldi, Maarten van Smeden, Stephan Harbarth, Jesús Rodríguez‐Baño and Valentijn A. Schweitzer and has published in prestigious journals such as European Respiratory Journal, Intensive Care Medicine and Clinical Microbiology and Infection.

In The Last Decade

J-F. Timsit

18 papers receiving 124 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J-F. Timsit France 5 60 36 36 32 24 20 126
Nadezhda Zubareva Russia 6 28 0.5× 43 1.2× 23 0.6× 20 0.6× 17 0.7× 26 125
Christopher Cooper United States 6 22 0.4× 56 1.6× 40 1.1× 30 0.9× 24 1.0× 13 177
Piret Mitt Estonia 6 54 0.9× 44 1.2× 30 0.8× 30 0.9× 31 1.3× 10 201
Mônica Lajana Oliveira de Almeida Portugal 6 40 0.7× 77 2.1× 48 1.3× 57 1.8× 29 1.2× 8 201
Julia Praena Spain 7 76 1.3× 24 0.7× 45 1.3× 14 0.4× 14 0.6× 8 115
Juliano Gasparetto Brazil 9 82 1.4× 45 1.3× 40 1.1× 18 0.6× 33 1.4× 21 181
Gregory M. Schrank United States 7 64 1.1× 70 1.9× 27 0.8× 41 1.3× 26 1.1× 21 210
Jolanta Gulbinovič Lithuania 8 68 1.1× 30 0.8× 12 0.3× 11 0.3× 12 0.5× 9 203
Marcella Sibani Italy 7 75 1.3× 45 1.3× 26 0.7× 22 0.7× 14 0.6× 12 197
Avnish Sandhu United States 6 34 0.6× 35 1.0× 30 0.8× 20 0.6× 6 0.3× 12 125

Countries citing papers authored by J-F. Timsit

Since Specialization
Citations

This map shows the geographic impact of J-F. Timsit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J-F. Timsit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J-F. Timsit more than expected).

Fields of papers citing papers by J-F. Timsit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J-F. Timsit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J-F. Timsit. The network helps show where J-F. Timsit may publish in the future.

Co-authorship network of co-authors of J-F. Timsit

This figure shows the co-authorship network connecting the top 25 collaborators of J-F. Timsit. A scholar is included among the top collaborators of J-F. Timsit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J-F. Timsit. J-F. Timsit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rasigade, Jean‐Philippe, J-F. Timsit, Philippe Vanhems, et al.. (2021). Automated surveillance in French ICUs: is it feasible? Results from a survey in French ICUs participating in a surveillance network. Journal of Hospital Infection. 115. 1–4.
2.
3.
Lévy-Bachelot, L., Bernard Castan, Raymond Ruimy, et al.. (2020). PIN91 Ceftolozane-Tazobactam for the Treatment of Pneumonia Due to MULTI-Drug Resistant Ps eudomonas Aeruginosa - Results from a French Real-World Study. Value in Health. 23. S560–S560.
4.
Dang, Elizabeth, Minh Lê, Mathilde Neuville, et al.. (2020). Plasma pharmacokinetics of bedaquiline administered by nasogastric tube in an intensive care unit. The International Journal of Tuberculosis and Lung Disease. 24(1). 110–112. 1 indexed citations
5.
Schweitzer, Valentijn A., Cornelis H. van Werkhoven, Jasmin Islam, et al.. (2018). The quality of studies evaluating antimicrobial stewardship interventions: a systematic review. Clinical Microbiology and Infection. 25(5). 555–561. 50 indexed citations
6.
Milpied, B., et al.. (2016). Herpes génital. Annales de Dermatologie et de Vénéréologie. 143(11). 729–733. 2 indexed citations
7.
Barbier, François, Maïté Garrouste-Orgeas, Carole Schwebel, et al.. (2015). EXTENDED-SPECTRUM BETA-LACTAMASE-PRODUCING ENTEROBACTERIACEAE IN CRITICALLY ILL PATIENTS: IMPACT OF CARRIAGE AND INFECTION ON CARBAPENEM CONSUMPTION, DURATION OF ICU STAY, AND MORTALITY. Intensive Care Medicine Experimental. 3(Suppl 1). A1–A1. 3 indexed citations
8.
Dimοpoulos, George, Despoina Koulenti, Alexis Tabah, et al.. (2015). Bloodstream infections in ICU with increased resistance: epidemiology and outcomes.. PubMed. 81(4). 405–18. 22 indexed citations
9.
Garrouste-Orgeas, Maïté, Adeline Max, Charles Grégoire, et al.. (2015). IMPACT OF PROACTIVE NURSE PARTICIPATION IN ICU FAMILY CONFERENCES: A MIXED-METHOD STUDY. Intensive Care Medicine Experimental. 3(Suppl 1). A929–A929. 1 indexed citations
10.
Timsit, J-F., Giuseppe Citerio, Anders Perner, et al.. (2015). DETERMINANTS OF DOWNLOADS AND CITATIONS FOR ARTICLES PUBLISHED IN INTENSIVE CARE MEDICINE. Intensive Care Medicine Experimental. 3(Suppl 1). A863–A863. 1 indexed citations
11.
Mimoz, Olivier, Thomas Kerforne, Bertrand Souweine, et al.. (2015). Chlorhexidine-alcohol versus povidone iodinealcohol antisepsis for catheter-related infection prevention: an open-label, multicentre, randomised controlled trial. Intensive Care Medicine Experimental. 3(S1). 3 indexed citations
12.
Coupez, Elisabeth, J-F. Timsit, Alexandre Boyer, et al.. (2015). Guidewire exchange vs new-site placement for temporary dialysis catheters insertion in ICU patients: is there a greater risk of colonization or dysfunction?. Intensive Care Medicine Experimental. 3(S1). 1 indexed citations
13.
Bekaert, Maarten, J-F. Timsit, Johan Decruyenaere, et al.. (2009). EXCESS RISK OF DEATH FROM VENTILATOR ASSOCIATED PNEUMONIA: A REAPPRAISAL USING LONGITUDINAL CAUSAL ANALYSIS. Intensive Care Medicine. 35. 16–16. 2 indexed citations
14.
Mounier, Rémi, Christophe Adrie, Adrien Français, et al.. (2009). Study of prone positioning to reduce ventilator-associated pneumonia in hypoxaemic patients. European Respiratory Journal. 35(4). 795–804. 17 indexed citations
15.
Timsit, J-F., et al.. (2008). Cancer bronchopulmonaire et réanimation. Revue de Pneumologie Clinique. 64(5). 250–256. 3 indexed citations
16.
17.
Feuvre, Claude Le, et al.. (2004). Cumulative adverse effects of diabetes mellitus and hypertension on coronary flow velocity reserve.. PubMed. 97(9). 849–54. 4 indexed citations
18.
Azoulay, Élie, Pierre Moine, Yves Cohen, & J-F. Timsit. (2001). [Nosocomial pneumopathy acquired under mechanical ventilation. Suspicion criteria, bacteriologic diagnosis, and remission criteria].. PubMed. 57(6). 380–90. 1 indexed citations
19.
Longrois, Dan, S Calvat, J-F. Timsit, et al.. (1996). [Pulmonary valve replacement for endocarditis. Apropos of 2 cases].. PubMed. 89(4). 471–5. 2 indexed citations
20.
Timsit, J-F., et al.. (1985). [Cardiovascular manifestations in hyperthyroidism. Recent physiopathological data; clinical and therapeutic aspects].. PubMed. 136(5). 430–45. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadezhda Zubareva Breakdown of academic impact, for papers by Christopher Cooper Breakdown of academic impact, for papers by Piret Mitt Breakdown of academic impact, for papers by Mônica Lajana Oliveira de Almeida Breakdown of academic impact, for papers by Julia Praena Breakdown of academic impact, for papers by Juliano Gasparetto Breakdown of academic impact, for papers by Gregory M. Schrank Breakdown of academic impact, for papers by Jolanta Gulbinovič Breakdown of academic impact, for papers by Marcella Sibani Breakdown of academic impact, for papers by Avnish Sandhu
Rankless by CCL
2026